◀ Back to AKT1
AKT1 — CD19
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Otero et al., J Biol Chem 2001
(Lymphoma, B-Cell) :
Using CD19-deficient B-lymphoma cells and mouse splenic B-cells, we show that
CD19 is
necessary for efficient activation of
Akt following cross linking of surface immunoglobulin or Igbeta
Inabe et al., Blood 2002
:
Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for
Akt activation in
response to
CD19 engagement
Johnson et al., J Immunol 2008
:
IL-7 stimulation of rested
CD19 ( + ) cells
resulted in robust induction of p-ERK1/2, but no induction of
AKT enzymatic activity
Dasu et al., Mol Immunol 2009
:
BCR and
CD19 co-cross linking
activates Akt , a key mediator of survival and proliferation signals downstream of PI3K in splenic B-2 cells